Real World Outcomes of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program with Commercial Lifileucel.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Cutaneous Melanoma Detection and Management
Publication details
- Journal / source
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Volume
- 32
- Issue
- 2
- Pages
- S180–S181
- Publication date
- 1 February 2026
- Language
- EN